2001
DOI: 10.1023/a:1012269804578
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators

Abstract: Our findings show that inactivation of suppressor genes, expression of oncogenes, loss of differentiation, augmentation of proliferative activity, metastatic potential, angiogenesis and hormone receptor status are all interrelated facets of breast cancer pathogenesis. Patients with tumors overexpressing c-erbB-2 or with bigger or higher-grade tumors probably need to be more carefully evaluated for the presence of distant metastasis, thus be better staged, at presentation. This may be a new reason to test c-erb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
15
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 16 publications
2
15
0
Order By: Relevance
“…Our study provides convincing evidence for a non-significant association between expression of ER, PR and lymph node metastasis. Similar results have been documented in other studies [16,17] .…”
Section: Discussionsupporting
confidence: 93%
“…Our study provides convincing evidence for a non-significant association between expression of ER, PR and lymph node metastasis. Similar results have been documented in other studies [16,17] .…”
Section: Discussionsupporting
confidence: 93%
“…Our study, as well as others, did not find a significant association between Her-2/neu overexpression and positive axillary lymph nodes (11,13,24,25). Tumor size is one of the most useful predictors of tumor behavior in breast cancer.…”
Section: Discussionsupporting
confidence: 60%
“…The p53 status (mutated, null, or wild-type) of tumors often correlates with its metastatic potential (41). The effect of NO on MB231 (mutant p53) and MB 157 (p53-null) human breast cancer cell lines was evaluated.…”
Section: Resultsmentioning
confidence: 99%